RAAS inhibition in patients with kidney disease: Balancing the benefits and risks

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Managing hyperkalemia in cardiorenal patients: novel therapeutic insights to optimize outcomes
Managing hyperkalemia in cardiorenal patients: novel therapeutic insights to optimize outcomes
RAASi and Hyperkalaemia in Cardio Renal Disease
Managing hyperkalemia in cardiorenal patients: novel therapeutic insights to optimize outcomes
- Prof. Matthew Weir, MD
Addressing the risk of hyperkalemia in HF: is there a sweet spot for potassium binding?
Addressing the risk of hyperkalemia in HF: is there a sweet spot for potassium binding?
RAASi and Hyperkalaemia in Cardio Renal Disease
Addressing the risk of hyperkalemia in HF: is there a sweet spot for potassium binding?
- Prof. van der Meer, MD, PhD